These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36943306)

  • 1. Characterization of dominant-negative growth hormone receptor variants reveals a potential therapeutic target for short stature.
    Andrews A; Cottrell E; Maharaj A; Ladha T; Williams J; Schilbach K; Kaisinger LR; Perry JRB; Metherell LA; McCormick PJ; Storr HL
    Eur J Endocrinol; 2023 Apr; 188(4):353-365. PubMed ID: 36943306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical review 112: Does serum growth hormone (GH) binding protein reflect human GH receptor function?
    Amit T; Youdim MB; Hochberg Z
    J Clin Endocrinol Metab; 2000 Mar; 85(3):927-32. PubMed ID: 10720017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel GHR intronic variant, c.266+83G>T , activates a cryptic 5' splice site causing severe GHR deficiency and classical GH insensitivity syndrome.
    Feigerlova E; Swinyard M; Derr MA; Farnsworth J; Andrew SF; Rosenfeld RG; Hwa V
    Horm Res Paediatr; 2013; 80(6):397-405. PubMed ID: 24296660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe growth failure associated with a novel heterozygous nonsense mutation in the GHR transmembrane domain leading to elevated growth hormone binding protein.
    Rughani A; Zhang D; Vairamani K; Dauber A; Hwa V; Krishnan S
    Clin Endocrinol (Oxf); 2020 Apr; 92(4):331-337. PubMed ID: 31883394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The growth hormone receptor (GHR) c.899dupC mutation functions as a dominant negative: insights into the pathophysiology of intracellular GHR defects.
    Derr MA; Aisenberg J; Fang P; Tenenbaum-Rakover Y; Rosenfeld RG; Hwa V
    J Clin Endocrinol Metab; 2011 Nov; 96(11):E1896-904. PubMed ID: 21900382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone (GH) insensitivity syndrome with high serum GH-binding protein levels caused by a heterozygous splice site mutation of the GH receptor gene producing a lack of intracellular domain.
    Iida K; Takahashi Y; Kaji H; Nose O; Okimura Y; Abe H; Chihara K
    J Clin Endocrinol Metab; 1998 Feb; 83(2):531-7. PubMed ID: 9467570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and biochemical consequences of an intragenic growth hormone receptor (GHR) deletion in a large Chinese pedigree.
    Klammt J; Shen S; Kiess W; Kratzsch J; Stobbe H; Vogel M; Luo F; Pfäffle R
    Clin Endocrinol (Oxf); 2015 Mar; 82(3):453-61. PubMed ID: 25196842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth Hormone Receptor Mutations Related to Individual Dwarfism.
    Lin S; Li C; Li C; Zhang X
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29748515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extreme elevation of serum growth hormone-binding protein concentrations resulting from a novel heterozygous splice site mutation of the growth hormone receptor gene.
    Aalbers AM; Chin D; Pratt KL; Little BM; Frank SJ; Hwa V; Rosenfeld RG
    Horm Res; 2009; 71(5):276-84. PubMed ID: 19339792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A short isoform of the human growth hormone receptor functions as a dominant negative inhibitor of the full-length receptor and generates large amounts of binding protein.
    Ross RJ; Esposito N; Shen XY; Von Laue S; Chew SL; Dobson PR; Postel-Vinay MC; Finidori J
    Mol Endocrinol; 1997 Mar; 11(3):265-73. PubMed ID: 9058373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel, Heterozygous, de novo Splicing Variant Affecting the Intracellular Domain of the Growth Hormone Receptor, and Causing a Mild Short Stature.
    Giannakopoulos A; Papanastasiou AD; Zarkadis IK; Andrew SF; Rosenfeld RG; Efthymiadou A; Chrysis D; Hwa V
    Horm Res Paediatr; 2024; 97(4):397-403. PubMed ID: 37725936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The GH receptor and GH insensitivity.
    Ross RJ
    Growth Horm IGF Res; 1999 Jun; 9 Suppl B():42-5; discussion 45-6. PubMed ID: 10549305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Dominant-Negative GH Receptor Mutations Expands the Spectrum of GHI and IGF-I Deficiency.
    Vairamani K; Merjaneh L; Casano-Sancho P; Sanli ME; David A; Metherell LA; Savage MO; Del Pozo JS; Backeljauw PF; Rosenfeld RG; Aisenberg J; Dauber A; Hwa V
    J Endocr Soc; 2017 Apr; 1(4):345-358. PubMed ID: 29188236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterisation of a novel GHR defect disrupting the polypyrimidine tract and resulting in GH insensitivity.
    David A; Miraki-Moud F; Shaw NJ; Savage MO; Clark AJ; Metherell LA
    Eur J Endocrinol; 2010 Jan; 162(1):37-42. PubMed ID: 19812236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of different growth hormone (GH) mutants on the regulation of GH-receptor gene transcription in a human hepatoma cell line.
    Deladoëy J; Gex G; Vuissoz JM; Strasburger CJ; Wajnrajch MP; Mullis PE
    Eur J Endocrinol; 2002 Apr; 146(4):573-81. PubMed ID: 11916628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional characterization of truncated growth hormone (GH) receptor-(1-277) causing partial GH insensitivity syndrome with high GH-binding protein.
    Iida K; Takahashi Y; Kaji H; Takahashi MO; Okimura Y; Nose O; Abe H; Chihara K
    J Clin Endocrinol Metab; 1999 Mar; 84(3):1011-6. PubMed ID: 10084588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone stimulates hepatic expression of bovine growth hormone receptor messenger ribonucleic acid through signal transducer and activator of transcription 5 activation of a major growth hormone receptor gene promoter.
    Jiang H; Wang Y; Wu M; Gu Z; Frank SJ; Torres-Diaz R
    Endocrinology; 2007 Jul; 148(7):3307-15. PubMed ID: 17412814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical defects resulting in growth hormone insensitivity.
    Wit JM; de Luca F
    Growth Horm IGF Res; 2016 Jun; 28():57-61. PubMed ID: 26670721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary growth hormone (GH) insensitivity and insulin-like growth factor deficiency caused by novel compound heterozygous mutations of the GH receptor gene: genetic and functional studies of simple and compound heterozygous states.
    Fang P; Riedl S; Amselem S; Pratt KL; Little BM; Haeusler G; Hwa V; Frisch H; Rosenfeld RG
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2223-31. PubMed ID: 17405847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel heterozygous STAT5B variant in a patient with short stature and partial growth hormone insensitivity (GHI).
    Ramírez L; Sanguineti N; Scaglia P; Keselman A; Ballerini MG; Karabatas L; Landi E; Castro J; Domené S; Pennisi P; Jasper H; Rey RA; Vázquez M; Domené H; Bergadá I; Gutiérrez M
    Growth Horm IGF Res; 2020 Feb; 50():61-70. PubMed ID: 31902742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.